Skip to main content

Table 1 Baseline characteristics of HIV infected and non-infected women at the time of cervical cancer diagnosis

From: Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting

  Total
(N = 270)
HIV infected
(N = 123)
HIV non-infected
(N = 147)
Histology
 Squamous Cell Carcinoma 251 (93) 117 (95.1) 134 (91.2)
 Adenocarcinoma 16 (5.9) 4 (3.3) 12 (8.2)
 No histology available 3 (1.1) 2 (1.6) 1 (0.7)
Disease severity stage
 Early stage I-IIA 28 (10.4) 16 (13.0) 12 (8.2)
 Advanced stage IIB-IIIB 152 (56.3) 71 (57.7) 81 (55.1)
 Late stage IV 5 (1.9) 1 (0.8) 4 (2.7)
 Missing information 85 (31.5) 35 (28.5) 50 (34.0)
Age at diagnosis in years, median (range) 49.8 (21–87) 44.8 (21–76) 55.9 (31–87)
Marital Status
 Single 45 (1.9) 3 (2.6) 1 (0.7)
 Married 147 (54.4) 55 (48.3) 87 (59.2)
 Widowed 103 (38.2) 48 (42.1) 52 (35.4)
 Divorced or separated 15 (5.6) 7 (6.1) 7 (4.8)
Pregnancies & Birth
 Gravidity, median (range) 6 (0–23) 4 (0–13) 7 (0–23)
 Parity, median (range) 5 (0–20) 4 (0–12) 6 (0–20)
Education
 No education 106 (39.3) 27 (22) 79 (53.7)
 Basic education 153 (56.7) 89 (72.4) 64 (43.5)
 Advanced education 11 (4.1) 7 (5.7) 4 (2.7)
Antiretroviral treatment (ART)
 On ART   88 (71.6)  
 -Years on ART, median (range)   4,5 (0–20)  
 - < 1 year on ART   15 (12.2)  
 - ≥ 1 year on ART   62 (50.4)  
 Not on ART   23 (18.7)  
 Not known   12 (9.8)  
CD4 Counts
 Recent CD4 count, median (range)   365 (11–1226)  
 - ≤ 200 cells/µl   25 (20.3)  
 -200–349 cells /µl   31 (25.2)  
 - ≥ 350 cells /µl   68 (55.3)  
 Lowest CD4 count, median (range)   231 (5–1158)  
 - < 200 cells /µl   48 (39)  
 CD4 cell count not known   5 (4.1)  
WHO Stages
 Stages 1–2   90 (73,2)  
 Stages 3–4   19 (15.5)  
 Not known   14 (11.4)  
Clinical Presentation
 Any symptoms 249 (92.2) 110 (89,4) 139 (94.6)
 No symptoms 21 (7.8) 13 (10,6) 8 (5.4)
 Lower abdominal pain 177 (65.6) 79 (64,2) 98 (66.7)
 Abnormal vaginal discharge 223 (82.6) 96 (78.1) 127 (86.4)
 Abnormal menstrual bleeding 62 (23) 34 (27.6) 28 (19.1)
 -Intermenstrual bleeding 39 (14.4) 27 (22) 12 (8.2)
 -Prolonged menstrual bleeding 29 (10.7) 10 (8.1) 19 (12.9)
 Sexually active N = 85 N = 46 N = 39
 -Post-coital bleeding 60 (70.6) 34 (73.9) 26 (66.7)
 -Pain during sex 70 (82.4) 38 (82.6) 32 (82.1)